Xconomy Boston

Craig’s first post…

Craig Smith6/13/08Leave a Comment

…is coming soon.

Craig A. Smith is co-founder and chairman of the scientific advisory board of VLST Corp. His research accomplishments at Seattle-based Immunex include having cloned a receptor for TNF that led to the development of Enbrel for autoimmune diseases such as rheumatoid arthritis.

Related Topics

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.